CRISPR Therapeutics AG
Open
SectorHealthcare
50.64 -4.85
Overview
Share price change
24h
Min
50.46
Max
53.22
Income | 7.7M -123M |
|---|---|
Sales | 594K 1.5M |
EPS | -1.28 |
Profit margin | -8,431.481 |
Employees | 393 |
EBITDA | 31M -118M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +38.43% upside |
Next Earnings | 31 Jul 2026 |
|---|
Market Cap | 1.2B 6.1B |
|---|---|
Previous open | 55.49 |
Previous close | 50.64 |
News Sentiment
By Acuity
60%
40%
272 / 342 Healthcare
CRISPR Therapeutics AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
CRISPR Therapeutics AG Forecast
Price Target
By TipRanks
12 Months Forecast
Average 73.85 USD 38.43%
High 110 USD
Low 45 USD
Based on 14 Wall Street analysts offering 12 month price targets forCRISPR Therapeutics AG - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$